Health-care companies fell, but not by much, as traders continued rotating out of tech into lagging sectors.

Health-care companies ticked down as deal activity offset fears about generic competition for one key category of drugs.

Health-care companies fell, but not by much, as traders continued rotating out of tech into lagging sectors.

Health-care companies rose, but not by as much as the broad market, as traders rotated back into the tech sector.